Procaps Group S.A. (NASDAQ:PROC – Get Rating) traded up 5.6% on Monday . The stock traded as high as $4.76 and last traded at $4.75. 7,148 shares were traded during trading, a decline of 87% from the average session volume of 53,325 shares. The stock had previously closed at $4.50.
Procaps Group Stock Performance
The firm has a 50 day simple moving average of $5.80 and a two-hundred day simple moving average of $6.88.
Get
Procaps Group alerts:
Procaps Group (NASDAQ:PROC – Get Rating) last released its earnings results on Monday, November 14th. The company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.09. Procaps Group had a negative return on equity of 243.60% and a net margin of 13.82%. The firm had revenue of $110.40 million during the quarter, compared to analysts' expectations of $123.90 million. On average, equities analysts anticipate that Procaps Group S.A. will post 0.12 EPS for the current fiscal year.
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the stock. State Street Corp acquired a new position in shares of Procaps Group during the third quarter worth $89,000. Citadel Advisors LLC acquired a new position in shares of Procaps Group during the second quarter worth $263,000. Finally, Millennium Management LLC increased its holdings in shares of Procaps Group by 15.9% during the second quarter. Millennium Management LLC now owns 101,430 shares of the company's stock worth $945,000 after buying an additional 13,908 shares in the last quarter. 0.95% of the stock is currently owned by institutional investors and hedge funds.
About Procaps Group
(Get Rating)
Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.
Recommended Stories
- Get a free copy of the StockNews.com research report on Procaps Group (PROC)
- Tractor Supply Company Shares Could be Headed to New Highs
- Is Canadian Solar Too Hot to Handle?
- UiPath is the Blue-Collar AI Platform to Watch in 2023
- CVS Health is Growing into an Integrated Healthcare Organization
- NVIDIA Outlook Improving: Watchlist Candidate for 2023
Receive News & Ratings for Procaps Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procaps Group and related companies with MarketBeat.com's FREE daily email newsletter.
